Browsing by Title :

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 11461 to 11480 of 17778

Pub YearTitleAJOU Author(s)
2022Pharmacy Newsletter Vol.18 No.11병원_부서약제팀
2022Pharmacy Newsletter Vol.18 No.12병원_부서약제팀
2023Pharmacy Newsletter Vol.19 No.01병원_부서약제팀
2023Pharmacy Newsletter Vol.19 No.02병원_부서약제팀
2023Pharmacy Newsletter Vol.19 No.03병원_부서약제팀
2023Pharmacy Newsletter Vol.19 No.04병원_부서약제팀
2023Pharmacy Newsletter Vol.19 No.05병원_부서약제팀
2023Pharmacy Newsletter Vol.19 No.06병원_부서약제팀
2023Pharmacy Newsletter Vol.19 No.07병원_부서약제팀
2023Pharmacy Newsletter Vol.19 No.08병원_부서약제팀
2023Pharmacy Newsletter Vol.19 No.09병원_부서약제팀
2023Pharmacy Newsletter Vol.19 No.10병원_부서약제팀
2023Pharmacy Newsletter Vol.19 No.11병원_부서약제팀
2024Pharmacy Newsletter Vol.20 No.01병원_부서약제팀
2021Pharyngeal Airway Morphology in Skeletal Class III With Mandibular Asymmetry is Improved After Bimaxillary Orthognathic Surgery김영호, 신정원, 채화성
2013Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter syndrome).손영배
2019Phase II randomized study of neoadjuvant metformin plus letrozole versus placebo plus letrozole for ER-positive postmenopausal breast cancer [METEOR Study]정용식
2014Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR).정용식
2022Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy권민석
2021Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)강석윤

Browse